Submitted in complete fulfillment for the Degree of Master of Technology: Biotechnology, Durban University of Technology, Durban, South Africa, 2014. / Antibiotic resistance amongst bacterial pathogens is a crisis that has been worsening over recent decades, resulting in serious and often fatal infections that cannot be treated by conventional means. Diseases caused by these drug resistant agents result in protracted illnesses, greater mortality rates and increases in treatment costs. Improvements to existing therapies and the development of novel treatments are urgently required to deal with this escalating threat to human health. One of the more promising strategies to combat antibiotic resistance is the use of metallic nanoparticles. Research into this area has shown that the binding of antibiotics to nanoparticles enhances their antimicrobial effects, reduces side-effects due to requirement of lower dosages of the drug, concentrates the drug at the interaction site with bacterial cells and in certain cases, has re-introduced susceptibility into bacterial strains that have developed drug resistance. Furthermore, these nanoparticles can be used in cancer treatment in similar drug delivery roles. Based on the promising data that demonstrated the synergistic effects of antimicrobial agents with nanoparticles, the aim of our research is to determine the effect of ciprofloxacin-conjugated gold nanoparticles as antimicrobial agents. To achieve this aim our objectives were: (i) to synthesize citrate-capped and ciprofloxacin-conjugated gold nanoparticles; (ii) to determine the physical and chemical characteristics of the ciprofloxacin-nanoparticle hybrid molecule; (iii) to investigate the antimicrobial activity of the conjugated nanoparticles against various species of common pathogens and (iv) to investigate the anti-cancer potential of the citrate-capped nanoparticles against a Caco-2 cell line. In this study, citrate-capped gold nanoparticles were conjugated to the antibiotic, ciprofloxacin, and their antibacterial and anti-cancer activity was evaluated. Initial experiments involved the synthesis and characterization of gold nanoparticles and ciprofloxacin conjugated nanoparticles. The gold nanoparticles were synthesized using the Turkevich citrate reduction technique which has been extensively used in studies thus far. The synthesized nanoparticles were characterized for specific absorbance using a UV-Spectrophotometer. The bond between the nanoparticles and ciprofloxacin was characterized by FTIR. Ultra structural details of the gold nanoparticles were established by TEM. The colloidal stability of the nanoparticles was determined by spectroscopic analysis. The antibacterial activity of the ciprofloxacin-conjugated gold nanoparticles was studied by exposure to pathogenic bacteria (Staphyloccocus aureus, E. coli, Klebsiella pneumoniae, Enterocococcus spp., Enterobacter spp., and Psuedomonas spp.). MIC values were measured to give indication of antimicrobial effect. These bactericidal properties of the conjugate nanoparticles were further investigated by electron microscopy. To evaluate the action of the citrate capped gold nanoparticles on cancer cells, we exposed Caco-2 cells to various concentrations of the nanoparticles and its effect was evaluated by measuring the viability of the cells. The results showed that 0.5 mM trisodium citrate reduced gold chloride to yield gold nanoparticles, which were spherical and 15 to 30 nm (by TEM characterization) and had an absorption maxima of 530 nm. The ciprofloxacin conjugated nanoparticles had an absorption maxima of 667nm. The colloidal stability, which is used to assess whether the synthesized particles will retain their integrity in solution showed that citrate-capped GNPs were most stable at 37°C over a 14 day storage period while ciprofloxacin-conjugated GNPs were found to be most stable at 4°C over a 14 day period. The FTIR results showed that chemical bonding in the conjugated nanoparticles occurs between the pyridone moiety of ciprofloxacin and the nanoparticle surface. The antimicrobial results of ciprofloxacin-conjugated GNPs had a significantly improved killing response compared to ciprofloxacin on both Gram positive and Gram negative bacteria. The citrate-capped GNPs are shown to exert a similar cytotoxic effect to gemcitabine on the Caco-2 cell line at a concentration of 0.5 mM. These results indicate that combining gold nanoparticles and ciprofloxacin enhances the antimicrobial effect of the antibiotic. The conjugate nanoparticles increase the concentration of antibiotics at the site of bacterium-antibiotic interaction, and thus enhance the binding and entry of antibiotics into bacteria. This has great implications for treatment of infection, as these antibiotic-conjugated nanoparticles can be incorporated into wound dressings, be administered intravenously as drug delivery agents, be engineered to possess multiple functionalities in addition to antibacterial activity and act as dual infection tracking and antimicrobial agents. Likewise, in this study, gemcitabine, an anticancer drug and gold nanoparticles were shown to kill cancer cells. In addition to their use in photothermal therapy and as drug delivery agents, the nanoparticles themselves possess anti-cancer activity against the Caco-2 cells. Thus, they have potential to act alone as a form of cancer treatment if functionalized with certain targeting agents that are specific to cancer cells, reducing the side-effects that come with regular chemotherapeutic drugs. It can be concluded that ciprofloxacin-conjugated gold nanoparticles enhance antibacterial effects of the antibiotic ciprofloxacin against bacterial cells and citrate-capped gold nanoparticles have anti-cancer activity against the Caco-2 cell line.

Thesis (MSc)--University of Stellenbosch, 2004. / ENGLISH ABSTRACT: The ability of biofilms to resist antimicrobial treatment, when planktonic microbes cannot, is of not only fundamental scientific interest, but also a concern in industrial and medical fields. The inability to control biofouling of water distribution networks and products, as well as recurrent infections of implanted medical devices, is not only costly, but also potentially lethal. Several mechanisms whereby biofilms are able to evade antibiotic and biocidal agents have been proposed and investigated, but no universally relevant characteristic has been identified. . Initial investigation, involving BacLightTh ! LIVEIDEAD viability probes, epifluorescence microscopy and image analysis into the ability of natural biofilm and planktonic populations, .cultured in situ in a cooling tower, to survive treatment with a commercial biocide was not conclusive. Subsequent laboratory experimentation with a bacterial isolate from the cooling tower water revealed that the ability of attached biofilms to resist antimicrobial treatment exceeded that of planktonic cells shed from the biofilm. The reduced ability of suspended cells to survive antimicrobial treatment was not statistically significant, compared to that of the biofilm (P = 0.05). This is in contrast to the wealth of literature published on the subject of biofilm antimicrobial resistance The dilution rate in the flowcells in which biofilms were cultivated was more than 100 times higher than the maximum specific growth rate of the test organism. Nevertheless, there was typically more than I x 108 cells/ml in the effluent, suggesting that a metabolically active, rapidly dividing layer of cells existed at the biofilm bulk-liquid interface, from where daughter cells continuously detached. Treatment with an antimicrobial agent resulted in a significant reduction in the viability and number of cells detached from the biofilm, suggesting that this metabolically active layer of the biofilm was more sensitive to antimicrobial treatment, possibly due to a higher specific growth rate. Antimicrobial resistance was shown to be affected by the growth rate for planktonic bacterial populations, with an increased ability to survive, correlated with a decrease in specific growth rate. This supports the contention that growth rate plays a role in the susceptibility of the active layer. The bacterial cells in the layers closest to the attachment surface of the biofilm has frequently been shown to be slow growing, due to nutrient and oxygen limitation, while the outer biofilm layer is more susceptible to unfavourable environmental conditions. It is possible that such differentiation, which results in a responsive outer biofilm layer, provides a mechanism for the protection of the cells in the deeper layers, and thus survival over time. The results presented here support several hypotheses put forth in literature to account for the increased resistance of biofilms towards antimicrobial agents. Future work will include an investigation into changes in the patterns of gene expression when a bacteria becomes attached to a surface, upon subsequent release from the biofilm, and the influence this has on the ability to resist antimicrobial treatment. / AFRIKAANSE OPSOMMING: Die vermoë van aangehegte mikrobes, in teenstelling met vrydrywende mikroorganismes, om behandeling met antimikrobiese middels te oorleef, is nie net van belang vanuit 'n fundamenteel wetenskaplike oogpunt nie, maar ook betekenisvol vir die industriële en mediese velde. Die beheer van bio-bevuiling van waterverspreidingsnetwerke en produkte, sowel as herhaalde infeksies van mediese inplantings, is nie net van kostebelang nie, maar ook potensieël lewensgevaarlik. Verskeie meganismes wat biofilms in staat stelom antimikrobiese behandeling te oorleef, IS voorgestel en ondersoek, maar geen alomteenwoordige eienskap is tot dusver geïdentifiseer nie. Aanvanklike ondersoeke na die vermoë van natuurlike biofilms en planktoniese 'gemeenskappe, om biosiedbehandeling in situ in 'n lugversorgingskoeltoring se water te oorleef, was onbeslis. Die eksperimentele metodes het gebruik gemaak van BacLight™ LIVE/DEAD lewensvatbaarheidkleurstof, epifluoressensie-mikroskopie en beeldanalise. Daaropvolgende ondersoeke met 'n bakteriese isolaat vanuit die koeltoring het daarop gedui dat biofilms beter in staat is om antimikrobiese behandeling te oorleef as selle wat vrygelaat word vanuit die biofilm. Die afname in the lewensvatbaarheid van vrydrywende selle, na afloop van biosiedbehandeling, was nie statisties beduidend in vergelyking met die van die biofilm nie (P = 0.05). Die bevinding is in teenstelling met wat algemeen aanvaar word in die literatuur. Die verdunningstempo waaronder die biofilms in die vloeiselle gekweek is, was meer as 100- voudig hoër as die maksimum spesifieke groeitempo van die toetsorganisme. Ten spyte hiervan was daar tipies meer as 1 x 108 selle/ml in die uitvloeisel teenwoordig. Dit dui op 'n metabolies aktiewe, vinnig verdelende laag selle in die boonste laag van die biofilm, naaste aan die vloeistof fase, waarvandaan dogterselle voortdurend vrygestel word. Behandeling met die antimikrobiese agent het 'n beduidende afname in die lewensvatbaarheid en aantal dogterselle tot gevolg gehad, wat lei tot die gevolgtrekking dat die metabolies aktiewe laag van die biofilm meer sensitief is vir antimikrobiese behandeling, moontlik weens 'n hoër spesifieke groeitempo. Daar is verder bewys dat die vermoë om die werking van die antimikrobiese middel teen te staan, afhanklik is van die spesifieke groeitempo van planktoniese populasies. 'n Afname in groeitempo word geassosieer met 'n toename in oorlewing na antimikrobiese behandeling, wat die voorstel dat die groeitempo van die aktiewe laag 'n rol speel in die vatbaarheid daarvan, ondersteun. Dit is bekend dat die metaboliese aktiwiteit van bakteriese selle nader aan die aanhegtingsoppervlak van die biofilm verlaag is, weens 'n afname in diffusie van suurstof en nutriente in daardie deel van die biofilm. Dit is moontlik dat hierdie differensiasie, wat lei tot die vatbaarheid van die buitenste laag van die biofilm vir ongunstige omgewingstoestande, 'n oorlewingsmeganisme daarstel wat die onderliggende selle beskerm. Die resultate wat hier voorgelê word, ondersteun verskeie hipoteses wat die verhoogde weerstandbiedendheid van biofilms teen antimikrobiese middels beskryf. Toekomstige werk sluit ondersoeke in na veranderende patrone van geenuitdrukking wat plaasvind wanneer 'n bakterie in aanraking kom met 'n oppervlak, vasheg en ook weer vrygestel word, asook die invloed hiervan op die vermoë om antimikrobiese behandeling te oorleef.

published_or_final_version / Ecology and Biodiversity / Master / Master of Philosophy

2 pp. / Originally published: 2001 / An onsite sewage treatment system or "septic system" is effective way to safely recycle household wastewater back into the natural environment. The key to effective treatment is proper design, system installation, responsible operation, and periodic maintenance. This article provides information about how to improve septic system performance by taking simple steps at home.

In the current study, the antibacterial efficacy of zeolites containing silver or copper ions or a combination of these metals was assessed against several diverse copper resistant (CuR) and copper sensitive (CuS) strains of clinically relevant bacterial species. CuR Pseudomonas putida was significantly reduced in comparison to the unamended zeolite control. Unexpectedly, a CuS P. putida strain with no reported metal resistance appeared to be more resistant to the zeolite containing either Ag or Ag/Cu than the CuR strain. Contrary to expectations, after three and six hours of exposure, the CuS Escherichia coli displayed significantly more resistance to the Ag/Cu and Cu treatments than the reportedly CuR E. coli. All three reportedly CuR strains of Salmonella enterica exhibited resistance to Cu and Ag, as well as to the combination of the two metals after three and six hours of exposure. The reductions observed after 24 hours for all three CuR strains with Cu alone were still statistically significant compared to that of the CuS S. enterica strain. In addition, two of the CuR strains were more resistant to silver after 24 hours of exposure, suggesting a shared resistance mechanism such a copper efflux pump that also removes silver ions from the cell. Both the CuR and CuS strains of E. faecium were highly resistant to all of the treatments. In general, after comparison of all the resistances with all the treatments, E. faecium was the most resistant species, P. putida was the least resistant species, and the Salmonella strains were more resistant than E. coli in most cases.

Device associated infections are a growing problem in the field of orthopaedics and dentistry. Bacteria adhering to implant surfaces and subsequent biofilm formation are challenging to treat with systemic administered antibiotics. Functionalization of implant surfaces with therapeutic coatings that are capable of inhibiting bacterial adhesion are therefore considered as a straight forward strategy to treat and prevent implant related infections. In this thesis, the use of crystalline, arc deposited TiO2 and biomimetic hydroxyapatite (HA) coatings were evaluated with respect to their potential as antibacterial surface modifications for bone-anchored implants. UV light induced photocatalysis of anatase dominated TiO2 coated surfaces was shown to provide a bactericidal effect against S. epidermidis under clinically relevant illumination times and doses. Major parts of the drug release work carried out was based on biomimetic HA (HA-B) coated fixation pins. The analysis of the coating characteristics revealed that the nanoporous structure of HA-B coatings in addition to the chemical composition and surface charge are essential parameters that influence the drug carrier performance. Loading by adsorption was demonstrated to be a feasible approach to quickly incorporate antibiotics. The controlled release of antibiotics was shown to facilitate bactericidal effects against S. aureus over application-relevant time periods, even when exposed to biomechanical forces during insertion into bone model materials. Antibiotic incorporation during coating growth was shown to promote somewhat longer drug release time periods than those obtained using adsorption loading. In summary, functionalization of implant surfaces with bioactive and biocompatible coatings is a promising concept to impact the clinical success for bone-anchored applications. The additional feature of optional, on-demand antibacterial properties of these coatings through either on-site drug release or photocatalytic antibacterial treatment is advantageous for the prevention and effective treatment of devices-associated infections. Both strategies provide an immediate response to the implant contamination by bacteria and are believed to contribute towards minimizing the origin of post-surgical infections, while at the same time improving the interfacial stability between implant and bone.

Mini-dissertation submitted in partial compliance with the requirements for the Master's Degree in Technology: Homoeopathy, Durban Institute of Technology, 2003. / The purpose of this study was to determine the efficacy of Alepidea amatymbica tincture and homoeopathic dilutions to the 1st and 6th decimal potency as compared to ethanol (negative control) in the in vitro inhibition of Escherichea coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Bacillus cereus in terms of the disc diffusion test. Vancomycin and gentamicin were included in the study as positive controls in order to account for plate-ta-plate variations in the sensitivity of the bacterial strains to antimicrobial substances. Antimicrobial activity was expressed as the ratio of the inhibition zone (mm) produced by the test substance and the inhibition zone (mm) produced by the two combined antibiotic discs. For this study 20 Mueller-Hinton agar plates were assigned to each bacterial species and were inoculated with their respective bacteria. Four dry filter paper discs and two antibiotic discs were placed equidistantly on each agar plate. The filter paper discs had been previously impregnated with one of the test substances or the negative control using a triple impregnation technique utilizing a micro-pipette. The plates were then incubated at 37\xB0 C. The diameters of the zones of inhibition were measured at 18 hours, 24 hours and 48 hours. Data was analysed by means of the Statistical Package for Social Sciences (SPSS). Statistical methods utilized were Friedmans' test, Mann-Whitney U test, and Kruskall - Wallis Non-Parametric Analysis of Variance by Rank test. / M

No description available.

La cavité buccale est un écosystème dynamique et complexe à l'équilibre fragile. A l'occasion de modifications des conditions environnementales ou d'une augmentation de la sensibilité de l'hôte, il y a rupture de cet équilibre. L'altération des conditions locales va permettre la croissance et le développement d'espèces pathogènes jusqu'alors faiblement représentées, ce qui va autoriser la survenue de diverses pathologies infectieuses orales. Devant l'insuffisance des solutions apportées par une prise en charge uniquement mécanique, des moyens supplémentaires doivent être envisagés. La stratégie probiotique ouvre une voie séduisante puisque l'on se propose de remplacer des bactéries pathogènes par des microorganismes ayant des effets bénéfiques sur la santé orale. L'objectif de ce travail vise donc à identifier des souches probiotiques parmi des isolats oraux de lactobacilles. Pour cela, soixante six souches ont été évaluées. Afin de prédire leur persistance orale, trois méthodes différentes d'évaluation de l'adhérence ont été utilisées : une méthode sur tube de verre, la méthode MATS et un modèle de biofilm monoespèce. Des études in vitro ont été conduites pour déterminer si les lactobacilles pouvaient inhiber des pathogènes carieux (Streptococcus mutans et Actinomyces viscosus) et certains pathogènes parodontaux (Fusobacterium nucleatum et Porphyromonas gingivalis) et pour identifier les mécanismes impliqués. Enfin, les capacités fermentaires de certaines souches ont été appréciées, afin d'éviter l'apparition d'effets délétères comme la déminéralisation carieuse. Trois souches seulement ont montré des capacités d'adhérence intéressantes. Selon les critères que nous avions défini pour caractériser une activité comme antibactérienne, aucune souche n'a inhibé P. gingivalis et 9 souches ont été retenues pour leur pouvoir inhibiteur contre les autres pathogènes. Le mode d'action précis de l'inhibition reste encore à préciser. Dans les conditions de cette étude, aucune des souches évaluées pour son activité fermentaire n'a présenté un risque cariogène. Ce travail a permis de mettre en évidence des souches intéressantes soit de part leur adhérence soit de part leur activité inhibitrice. Des études in vitro complémentaires semblent nécessaires (évaluation de la stimulation immunitaire, précision sur les mécanismes impliqués dans les effets observés) avant de poursuivre sur un modèle animal ou des études cliniques chez l'Homme. / The oral cavity is a complex and dynamic ecosystem with a delicate balance. On the occasion of changes in environmental conditions or an increase in the sensitivity of the host, a break can occur. The alteration of local conditions will allow the growth and development of pathogenic species hitherto poorly represented, which will allow the occurrence of various oral infectious diseases. Due to the lack of solutions given by a purely mechanical support, additional resources should be considered. Probiotic strategy appears as an attractive way since it proposes to replace pathogenic bacteria by microorganisms having beneficial effects on oral health. The aim of this study was therefore to identify probiotic strains among oral lactobacilli isolates. To this end, sixty-six strains were evaluated. To predict persistence in mouth, three different methods of assessing adherence were used: a method on glass tube, the MATS method and a monospecie biofilm model. In vitro studies were conducted to determine whether lactobacilli could inhibit caries pathogens (Streptococcus mutans and Actinomyces viscosus) and some periopathogens (Fusobacterium nucleatum and Porphyromonas gingivalis) and to identify the mechanisms involved. Finally, the fermentation capacity of certain strains was assessed in order to avoid the occurrence of adverse effects such as carious demineralization. Only three strains showed adhesion interesting capabilities. According to the criteria we defined to characterize an activity as antibacterial, no strain inhibited P. gingivalis and 9 strains were selected for their inhibitory potency against the others pathogens. The precise mode of action of the inhibition remains unclear. Under the conditions of this study, none of the strains tested for its fermentative activity has introduced a cariogenic risk. This work has highlighted interesting strains because of their adhesion or because of their inhibitory activity. Additional in vitro studies seem necessary (evaluation of immune stimulation, precision of the mechanisms involved in the observed effects) before continuing in an animal model and clinical studies in humans.

Les dendrimères greffés de L-lysine (DGL) ont des applications potentielles variées (agents antibactériens, antifongiques…). Ces dendrimères greffés sont obtenus selon un procédé original, mis au point au laboratoire, basé sur la polymérisation des N-carboxyanhydrides (NCA) de L-lysine. Les travaux de recherche décrits dans ce mémoire ont pour objectif d'évaluer (i) la faisabilité des différents modes de modification des DGL et (ii) l'activité antibactérienne des nouveaux conjugués synthétisés.Le manuscrit resitue d'abord les DGL parmi les différentes catégories de polymères dendritiques décrites dans la littérature. Il développe également les applications des oligo- et poly-ethylène glycols (OEG et PEG) comme agents pour la fonctionnalisation de molécules bioactives et la synthèse de bioconjugués. L'approche expérimentale de greffage d'oligo-homoarginines (Har)n à un DGL de troisième génération (DGL-G3) est ensuite abordée. Ces entités, ont été synthétisées de manière rapide et économique en introduisant les fonctions guanidinium à partir d'un DGL de première génération (DGL-G1) par une méthode innovante. La première partie de travail est consacrée à la synthèse de ces oligomères. La possibilité de greffage ultérieure de ces derniers nécessite la synthèse préalable de bras d'espacement bifonctionnels porteurs d'une fonction amine à une des extrémités et d'une fonction aldéhyde masquée à l'autre. L'amine de cet intermédiaire est destinée à amorcer la polymérisation du Lys(Tfa)-NCA, alors que l'aldéhyde sera utilisé pour l'ancrage covalent à la plateforme DGL-G3. La seconde partie de ce travail est consacrée à la conjugaison de l'oligomère (Har)n sur la plateforme DGL selon une réaction d'amination réductrice qui a été optimisée et à la synthèse de nouveaux conjugués portant des chaînes hydrophobes. Parmi tous les conjugués DGL synthétisés, seuls les ceux portant les chaînes hydrophobes ont amélioré l'activité antibactérienne. / L-Lysine dendrigrafts (DGLs) have various potential applications (antibacterial agents, antifungal agents…). These dendrigrafts are obtained according to an original procedure elaborated in our laboratory based on the polymerization of L-lysine N-carboxyanhydrides (Lys-NCA). The investigations carried out in the present dissertation are aimed at assessing (i) the feasibility of the different ways of modification of DGLs and (ii) the antibacterial activity of the synthesized conjugates. The manuscript begins by locating DGLs among the different categories of dendritic polymers reported in the literature. It also develops the applications of oligo- and poly-ethylene (OEG and PEG) as agents for the functionalization of bioactive molecules and for bioconjugate synthesis. An approach consisting in grafting third generation DGL (DGL-G3) with oligo-homoarginines (Har)n is then described. These entities have been synthesized from a first generation DGL (DGL-G1) using an innovative strategy for the elaboration of guanidinium-rich peptides in a straightforward and cheap strategy. The first part of this work is dedicated to the oligomer synthesis. The possibility of further grafting of the latter is conditioned by the preceding access to bifunctional spacers bearing an amino group on the one end and a masked aldehyde function on the other end. The amine will enable the initiation of Lys(Tfa)-NCA polymerization, whereas the aldehyde will serve for the covalent grafting to the DGL-G3 scaffold. The second part of this work is devoted to the DGL-G3 functionalization by the (Har)n oligomer through a reductive amination strategy that has been optimized and to the synthesis of new conjugates with hydrophobic side-chains. Among all the conjugates prepared, only those having hydrophobic chains lead to an increase in antibacterial activity.